69 related articles for article (PubMed ID: 21940045)
41. In vivo labelling system to study cell neighbourhoods.
Ombrato L
Nat Rev Cancer; 2022 Dec; 22(12):661. PubMed ID: 36175643
[No Abstract] [Full Text] [Related]
42. Antitumor effects of targeted killing of tumor-associated macrophages under photothermal conditions.
Wang B; Huang Y
Lasers Med Sci; 2022 Feb; 37(1):299-307. PubMed ID: 33439377
[TBL] [Abstract][Full Text] [Related]
43. The glyconanoparticle as carrier for drug delivery.
Zhang X; Huang G; Huang H
Drug Deliv; 2018 Nov; 25(1):1840-1845. PubMed ID: 30799659
[TBL] [Abstract][Full Text] [Related]
44. CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles.
Rubio-Navarro A; Carril M; Padro D; Guerrero-Hue M; Tarín C; Samaniego R; Cannata P; Cano A; Villalobos JM; Sevillano ÁM; Yuste C; Gutiérrez E; Praga M; Egido J; Moreno JA
Theranostics; 2016; 6(6):896-914. PubMed ID: 27162559
[TBL] [Abstract][Full Text] [Related]
45. Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.
Tarin C; Carril M; Martin-Ventura JL; Markuerkiaga I; Padro D; Llamas-Granda P; Moreno JA; García I; Genicio N; Plaza-Garcia S; Blanco-Colio LM; Penades S; Egido J
Sci Rep; 2015 Nov; 5():17135. PubMed ID: 26616677
[TBL] [Abstract][Full Text] [Related]
46. Glyconanomaterials for biosensing applications.
Hao N; Neranon K; Ramström O; Yan M
Biosens Bioelectron; 2016 Feb; 76():113-30. PubMed ID: 26212205
[TBL] [Abstract][Full Text] [Related]
47. Lectin-carbohydrate interactions on nanoporous gold monoliths.
Tan YH; Fujikawa K; Pornsuriyasak P; Alla AJ; Ganesh NV; Demchenko AV; Stine KJ
New J Chem; 2013 Jul; 37(7):2150-2165. PubMed ID: 24883017
[TBL] [Abstract][Full Text] [Related]
48. Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor.
Elvira G; García I; Benito M; Gallo J; Desco M; Penadés S; Garcia-Sanz JA; Silva A
PLoS One; 2012; 7(9):e44466. PubMed ID: 22957072
[TBL] [Abstract][Full Text] [Related]
49. Universal cell labelling with anionic magnetic nanoparticles.
Wilhelm C; Gazeau F
Biomaterials; 2008 Aug; 29(22):3161-74. PubMed ID: 18455232
[TBL] [Abstract][Full Text] [Related]
50. Specific labelling of cell populations in blood with targeted immuno-fluorescent/magnetic glyconanoparticles.
Gallo J; García I; Genicio N; Padro D; Penadés S
Biomaterials; 2011 Dec; 32(36):9818-25. PubMed ID: 21940045
[TBL] [Abstract][Full Text] [Related]
51. Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles.
Pittet MJ; Swirski FK; Reynolds F; Josephson L; Weissleder R
Nat Protoc; 2006; 1(1):73-9. PubMed ID: 17406214
[TBL] [Abstract][Full Text] [Related]
52. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
Cheon J; Lee JH
Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
[TBL] [Abstract][Full Text] [Related]
53. FSiNPs mediated improved double immunofluorescence staining for gastric cancer cells imaging.
He X; Ge J; Wang K; Tan W; Shi H; He C
Talanta; 2008 Sep; 76(5):1199-206. PubMed ID: 18761178
[TBL] [Abstract][Full Text] [Related]
54. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
[TBL] [Abstract][Full Text] [Related]
55. Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet?
Taylor A; Wilson KM; Murray P; Fernig DG; Lévy R
Chem Soc Rev; 2012 Apr; 41(7):2707-17. PubMed ID: 22362426
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
